Polivy 30 mg

Polivy (polatuzumab vedotin-piiq) is a medication indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), a type of non-Hodgkin lymphoma, in combination with bendamustine and rituximab, following at least two prior therapies, unless otherwise specified.

Each vial of Polivy 30 mg Infusion Concentrate Powder contains 30 mg of polatuzumab vedotin. After reconstitution, each milliliter contains 20 mg of polatuzumab vedotin.

Polivy 30 mg​ You can contact us to find out the price:

Contact for detailed information
Important Notice: We do not have any activities such as drug sales, drug supply or drug promotion on our site. In addition, there is no help or counseling service on medical matters on our site. All information on the site has been prepared for patients and doctors to have information about drugs. Our site is not under legal responsibility for the incomplete or not updated information on our site. Our users entering the site are deemed to have accepted these conditions. Please consult your doctor before using medication.
Related Keywords

Contact Now

You can contact us immediately to get information about our products and services, and to get answers to your questions.

Contact Now